BRIEF RESEARCH REPORT
Published on 04 Jan 2024
A germline JAK2 exon12 mutation and a late somatic CALR mutation in a patient with essential thrombocythemia
doi 10.3389/fonc.2023.1265022
- 1,127 views
- Frontiers in Oncology
- Hematologic Malignancies
- Research Topics
- Myeloproliferative Neoplasms: Biology and Treatment
Myeloproliferative Neoplasms: Biology and Treatment
10k
Total Downloads
34k
Total Views and Downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 11 Aug 2023
The clinical relevance of broad mutational screening of myeloproliferative neoplasms at diagnosis
doi 10.3389/fonc.2023.1190305
- 1,797 views
- 1 citation
ORIGINAL RESEARCH
Published on 10 Aug 2023
Characterization of engraftment dynamics in myelofibrosis after allogeneic hematopoietic cell transplantation including novel conditioning schemes
doi 10.3389/fonc.2023.1205387
- 1,866 views
ORIGINAL RESEARCH
Published on 21 Jul 2023
Cigarette smoke stimulates clonal expansion of Jak2V617F and Tet2-/- cells
doi 10.3389/fonc.2023.1210528
- 2,468 views
- 3 citations
REVIEW
Published on 13 Jul 2023
Epigenetics in myeloproliferative neoplasms
doi 10.3389/fonc.2023.1206965
- 2,617 views
REVIEW
Published on 09 Jun 2023
Myeloproliferative neoplasms – blurring the lines between cancer and chronic inflammatory disorder
doi 10.3389/fonc.2023.1208089
- 6,055 views
- 2 citations
MINI REVIEW
Published on 22 May 2023
Mutations, inflammation and phenotype of myeloproliferative neoplasms
doi 10.3389/fonc.2023.1196817
- 3,410 views
- 11 citations
REVIEW
Published on 18 May 2023
The multidisciplinary approach to eosinophilia
doi 10.3389/fonc.2023.1193730
- 7,588 views
- 7 citations
PERSPECTIVE
Published on 19 Jan 2023
An alternative dosing strategy for ropeginterferon alfa-2b may help improve outcomes in myeloproliferative neoplasms: An overview of previous and ongoing studies with perspectives on the future
doi 10.3389/fonc.2023.1109866
- 5,758 views
- 17 citations
ORIGINAL RESEARCH
Published on 23 Nov 2022
A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naïve, high-risk essential thrombocythemia as a primary treatment
doi 10.3389/fonc.2022.989984
- 1,558 views
- 1 citation
CASE REPORT
Published on 22 Nov 2022
Case report: Double L611S/V617L JAK2 mutation in a patient with polycythemia vera originally diagnosed with essential thrombocythemia
doi 10.3389/fonc.2022.937362
- 1,259 views
Published in
Frontiers in Oncology
- Hematologic Malignancies
Impact
- 34kTopic views
- 23kArticle views
- 10kArticle downloads